The Fcε‐receptor I pathway is crucial but not exclusive for basophil activation in patients with autoimmune forms of chronic spontaneous urticaria

Jörg, L.; Mueller‐Wirth, N.; Pecaric‐Petkovic, T.; Diaz, C.; Pichler, W.; Hausmann, O. (2020). The Fcε‐receptor I pathway is crucial but not exclusive for basophil activation in patients with autoimmune forms of chronic spontaneous urticaria. Journal of the European Academy of Dermatology and Venereology : JEADV, 34(12), e825-e827. Wiley 10.1111/jdv.16703

[img] Text
Acad_Dermatol_Venereol_-_2020_-_J_rg_-_The_Fc_receptor_I_pathway_is_crucial_but_not_exclusive_for_basophil_activation_in.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (168kB) | Request a copy

Ibrutinib, an irreversible and specific Bruton's tyrosine kinase (BTK) inhibitor, leads to complete inhibition of IgE/FcεRI-BTK degranulation of human basophils without affecting the signaling via G-protein coupled receptors (C5a, fMLP) [1;2]. Since autoantibodies in chronic spontaneous urticaria (CSU) either against the IgE/FcεRI complex or IgE play a relevant role in CSU [3;4], ibrutinib could, therefore, be a promising asset in basophil assays [5]. This in-vitro study aimed to differentiate between FcεRI dependent and independent pathways in autoimmune CSU (aiCSU).

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Rheumatology, Clinical Immunology and Allergology

UniBE Contributor:

Jörg, Lukas

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1468-3083

Publisher:

Wiley

Language:

English

Submitter:

Lukas Jörg

Date Deposited:

29 Jun 2020 17:33

Last Modified:

05 Apr 2022 10:28

Publisher DOI:

10.1111/jdv.16703

PubMed ID:

32491222

BORIS DOI:

10.48350/144530

URI:

https://boris.unibe.ch/id/eprint/144530

Actions (login required)

Edit item Edit item
Provide Feedback